HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Scottish First Episode Schizophrenia Study V. One-year follow-up. The Scottish Schizophrenia Research Group.

Abstract
Of 49 schizophrenic patients followed up 12 months after their first admission to hospital, only about 45% had experienced no relapse and had no schizophrenic symptoms; a poorer outcome was more often found in Feighner positive than Feighner negative schizophrenic patients. The patients' overall level of unemployment had more than doubled to 51%. In patients whose acute episodes responded to treatment, pimozide taken once weekly as maintenance therapy was as effective as intramuscular flupenthixol decanoate, but tardive dyskinesia appeared in two patients receiving weekly pimozide; the repeat psychometric assessment at 12 months found modest improvements, i.e. no evidence of intellectual decline, in Matrices, Block Design, and Digit Copying tests. Forty per cent of relatives still showed significant psychological distress, which correlated with patients' schizophrenic symptoms, and the relatives' social functioning remained poorer than that of a normal community sample.
Authors
JournalThe British journal of psychiatry : the journal of mental science (Br J Psychiatry) Vol. 152 Pg. 470-6 (Apr 1988) ISSN: 0007-1250 [Print] England
PMID3167396 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Thioxanthenes
  • Tranquilizing Agents
  • Pimozide
  • flupenthixol decanoate
  • Flupenthixol
Topics
  • Adaptation, Psychological
  • Cognition
  • Family
  • Flupenthixol (analogs & derivatives, therapeutic use)
  • Follow-Up Studies
  • Hospitalization
  • Humans
  • Interpersonal Relations
  • Pimozide (therapeutic use)
  • Prognosis
  • Schizophrenia (drug therapy, epidemiology)
  • Schizophrenic Psychology
  • Scotland
  • Social Adjustment
  • Thioxanthenes (therapeutic use)
  • Tranquilizing Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: